このエントリーをはてなブックマークに追加
ID 63232
フルテキストURL
fulltext.pdf 2.42 MB
著者
Ueno, Sayaka Department of Clinical Genomic Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Sudo, Tamotsu Section of Translational Research, Hyogo Cancer Center
Hirasawa, Akira Department of Clinical Genomic Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Kaken ID researchmap
抄録
Ataxia-telangiectasia mutated (ATM) functions as a key initiator and coordinator of DNA damage and cellular stress responses. ATM signaling pathways contain many downstream targets that regulate multiple important cellular processes, including DNA damage repair, apoptosis, cell cycle arrest, oxidative sensing, and proliferation. Over the past few decades, associations between germline ATM pathogenic variants and cancer risk have been reported, particularly for breast and pancreatic cancers. In addition, given that ATM plays a critical role in repairing double-strand breaks, inhibiting other DNA repair pathways could be a synthetic lethal approach. Based on this rationale, several DNA damage response inhibitors are currently being tested in ATM-deficient cancers. In this review, we discuss the current knowledge related to the structure of the ATM gene, function of ATM kinase, clinical significance of ATM germline pathogenic variants in patients with hereditary cancers, and ongoing efforts to target ATM for the benefit of cancer patients.
キーワード
hereditary tumors
ATM
DNA damage
redox homeostasis
tumor profiling
precision therapy
発行日
2022-01-04
出版物タイトル
International Journal Of Molecular Sciences
23巻
1号
出版者
MDPI
開始ページ
523
ISSN
1422-0067
NCID
AA12038549
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2022 by the authors.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.3390/ijms23010523
ライセンス
https://creativecommons.org/licenses/by/4.0/